logo
#

Latest news with #750.00

Bernstein Reaffirms Their Buy Rating on Toyota (TYIDF)
Bernstein Reaffirms Their Buy Rating on Toyota (TYIDF)

Business Insider

time2 days ago

  • Automotive
  • Business Insider

Bernstein Reaffirms Their Buy Rating on Toyota (TYIDF)

Bernstein analyst Masahiro Akita maintained a Buy rating on Toyota (TYIDF – Research Report) today and set a price target of Yen18,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Akita is an analyst with an average return of -2.9% and a 26.67% success rate. Akita covers the Consumer Cyclical sector, focusing on stocks such as Nissan Motor Co, Suzuki Motor, and Toyota Motor. In a report released on May 13, Macquarie also maintained a Buy rating on the stock with a Yen20,000.00 price target.

Jefferies Reaffirms Their Sell Rating on Rohto Pharmaceutical Co (RPHCF)
Jefferies Reaffirms Their Sell Rating on Rohto Pharmaceutical Co (RPHCF)

Business Insider

time3 days ago

  • Business
  • Business Insider

Jefferies Reaffirms Their Sell Rating on Rohto Pharmaceutical Co (RPHCF)

In a report released on May 29, Hisae Kawamoto from Jefferies maintained a Sell rating on Rohto Pharmaceutical Co (RPHCF – Research Report), with a price target of Yen1,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Kawamoto covers the Consumer Defensive sector, focusing on stocks such as Shiseido Company,Limited, Pigeon Corporation, and Kao. According to TipRanks, Kawamoto has an average return of -0.7% and a 42.11% success rate on recommended stocks. Rohto Pharmaceutical Co has an analyst consensus of Moderate Buy, with a price target consensus of $17.96.

Morgan Stanley Sticks to Its Hold Rating for Alps Alpine Co (APELF)
Morgan Stanley Sticks to Its Hold Rating for Alps Alpine Co (APELF)

Business Insider

time3 days ago

  • Business
  • Business Insider

Morgan Stanley Sticks to Its Hold Rating for Alps Alpine Co (APELF)

Morgan Stanley analyst Shoji Sato maintained a Hold rating on Alps Alpine Co (APELF – Research Report) on May 29 and set a price target of Yen1,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Alps Alpine Co has an analyst consensus of Moderate Sell, with a price target consensus of $10.30. APELF market cap is currently $2.02B and has a P/E ratio of 7.93.

Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)
Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)

Business Insider

time3 days ago

  • Business
  • Business Insider

Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)

Morgan Stanley analyst Shinichiro Muraoka maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen4,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Muraoka covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Daiichi Sankyo Company, and Shionogi & Co. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a Yen4,700.00 price target.

Morgan Stanley Keeps Their Hold Rating on Shionogi & Co (SGIOF)
Morgan Stanley Keeps Their Hold Rating on Shionogi & Co (SGIOF)

Business Insider

time3 days ago

  • Business
  • Business Insider

Morgan Stanley Keeps Their Hold Rating on Shionogi & Co (SGIOF)

In a report released yesterday, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on Shionogi & Co (SGIOF – Research Report), with a price target of Yen2,750.00. The company's shares closed last Wednesday at $15.20. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Muraoka is an analyst with an average return of -3.9% and a 33.33% success rate. Muraoka covers the Healthcare sector, focusing on stocks such as Shionogi & Co, SanBio Co, and Takeda Pharmaceutical Co. The word on The Street in general, suggests a Hold analyst consensus rating for Shionogi & Co with a $15.75 average price target. SGIOF market cap is currently $14.58B and has a P/E ratio of 11.57.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store